Sign inJoin waitlistJoin the waitlist

Irene Kang

Physician · City of Hope

Credentials: · ·

History

City of Hope
2022–Present

Hematology and Medical Oncology
University of Southern California/Los Angeles General Medical Center
2014–2017
Internal Medicine
Santa Clara Valley Healthcare
2011–2014
University of California, San Francisco School of Medicine
2007–2011

Research

Mechanisms of scent-tracking in humans
Nature Neuroscience · 2007 · 204 citations
Feasibility of high intensity interval training in patients with breast Cancer undergoing anthracycline chemotherapy: a randomized pilot trial
BMC Cancer · 2019 · 59 citations
Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations
Modern Pathology · 2016 · 55 citations

JM
Joanne Mortimer
11 papers
JL
Janice Lu
8 papers
Julie Lang
7 papers
Hope Rugo
6 papers
Alexis LeVee
5 papers · 5 as a fellow
KT
Karen Tsai
5 papers
Darcy Spicer
4 papers
FS
Fred Sattler
4 papers
Melissa Lechner
4 papers
Alicia Terando
3 papers
Jennifer Tseng
3 papers
Jo Chien
3 papers

Clinical trials

Biology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE Trial
Principal investigator · Not yet recruiting · Phase 1
City of Hope Medical Center
2026–2027
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2023–2032
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2023–2033
Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2022–2027